Cargando…
Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients
OBJECTIVE: Atherosclerosis is exaggerated in African American (AA) systemic lupus erythematosus (SLE) patients, with doubled cardiovascular disease (CVD) risk compared to White patients. The extent to which common Apolipoprotein L1 (APOL1) risk alleles (RA) contribute to this trend is unknown. This...
Autores principales: | Blazer, Ashira, Wang, Binhuan, Simpson, Danny, Kirchhoff, Tomas, Heffron, Sean, Clancy, Robert M., Heguy, Adriana, Ray, Karina, Snuderl, Matija, Buyon, Jill P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574561/ https://www.ncbi.nlm.nih.gov/pubmed/28850570 http://dx.doi.org/10.1371/journal.pone.0182483 |
Ejemplares similares
-
3448 Macrophages, APOL1 Genotype, & Immunometabolism in CVD (MAGIC
por: Blazer, Ashira D., et al.
Publicado: (2019) -
Apolipoprotein L1 risk genotypes in Ghanaian patients with systemic lupus erythematosus: a prospective cohort study
por: Blazer, Ashira, et al.
Publicado: (2021) -
From antibody insult to fibrosis in neonatal lupus - the heart of the matter
por: Buyon, Jill P, et al.
Publicado: (2003) -
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort
por: Saxena, Amit, et al.
Publicado: (2021) -
Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis
por: Hardt, Uta, et al.
Publicado: (2018)